BCLC-B primary liver cancer
Conditions
Interventions
group 1:CalliSpheres drug-loaded microspheres would be used
group 2:CalliSpheres drug-loaded microspheres would not be used
Sponsors
the First Affiliated Hospital of Dalian Medical University
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: (1) Age older than 18 years, sex unlimited; (2) Diagnosis of hepatocellular carcinoma; (3) Not suitable for resection or had percutaneous ablation; (4) No chemotherapyradiotherapy?artery embolization or other antitumor therapy; (5) The number of gland of tumor=3; (6) The Child-Pugh of liver function; (7) BCLC-B; (8) ECOG=1; (9) Expected survival time=12 weeks; (10) Informed and signed informed consent paper.
Exclusion criteria
Exclusion criteria: (1) Other primary tumors; (2) Women in gestational and lactational; (3) People who couldnt have measures with contraception; (4) Accumulation of liver tumor>50%; (5) Patients with advanced liver disease; (6) Cant find superselective arterial intro operation; (7) Blood vessel invasion or extrahepatic metastasis; (8) Initial Iodine uptake of arterial phase and portal vein; (9) Cant do MRI; (10) Contraindicantions of DSA?TACE and epirubicin.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| efficacy of 1, 3, and 6 month;disease control rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| overall survival;Time to progression; | — |
Countries
China
Contacts
Public ContactHongshuang Pan
Outcome results
None listed